© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Speciality drug prices are so costly that many patients skip or ration them.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Oncologist wins Senate backing by a vote of 72 to 18.
People who paid more money out-of-pocket filled fewer prescriptions and had shorter overall survival.
A look at what the law says about buying prescription drugs from Canada.
Insurance companies can no longer implement harmful co-pay accumulator policies.
10 strategies to keep down the costs of cancer care
Specialty-tier drugs for multiple sclerosis, cancer and other conditions account for more than 20 percent of total spending in Part D plans.
He believes that America has the resources to make drugs and treatment more affordable for everyone.
Experts are questioning whether the groups’ financial ties could push them to put drugmakers’ interests ahead of the people they represent...
Advocating for yourself is the best medicine.
A cancer diagnosis often means extreme financial stress—and fights with insurance providers.
Stop me if you’ve heard this one before.
Branded drugs with expired patents but without generic competition may keep prices high and ultimately hurt patients.
While this program is intended for brand and generic drugs, we know it will support more efficient development and production of generics.
A look at the 2019 State of the Union address
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
